Quinoxaline derivatives as PI3 kinase inhibitors
    1.
    发明授权
    Quinoxaline derivatives as PI3 kinase inhibitors 失效
    喹喔啉衍生物作为PI3激酶抑制剂

    公开(公告)号:US07592342B2

    公开(公告)日:2009-09-22

    申请号:US12117127

    申请日:2008-05-08

    IPC分类号: A61K31/498

    摘要: Invented is a method of inhibiting the activity/function of PI3 kinases using quinoxaline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoxaline derivatives.

    摘要翻译: 发明的是使用喹喔啉衍生物抑制PI3激酶活性/功能的方法。 还发明了一种治疗选自以下的一种或多种疾病状态的方法:自身免疫性疾病,炎性疾病,心血管疾病,神经变性疾病,变态反应,哮喘,胰腺炎,多器官功能衰竭,肾脏疾病,血小板聚集,癌症,精子活力,移植排斥反应, 通过施用喹喔啉衍生物的移植排斥和肺部损伤。